Atle Fund Management AB — 13F Holdings & Portfolio
CIK 1381843 · latest 13F-HR filed 2026-07-24
Atle Fund Management AB manages $371.7M in 13F-reported U.S. long-equity assets across 39 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are LLY (9.62%), MRK (6.55%), JNJ (5.84%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 3 new positions, exited 3, added to 21, and trimmed 9.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
STOCKHOLM, V7 SE-114 57
$371.7M
Long-equity book
39
Distinct positions
2026-06-30
Filed 2026-07-24
+3 / −3 / ↑21 / ↓9
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- JOHNSON & JOHNSON$9.8M +81.7%
- ELI LILLY & CO$8.9M +33.2%
- CVS HEALTH CORP$5.8M +63.1%
- ABBVIE INC$5.8M +55.9%
- REVOLUTION MEDICINES INC$4.6M +50.8%
Top Trims
- BRIDGEBIO PHARMA INC-$2.6M -21.9%
- BOSTON SCIENTIFC-$2.6M -29.4%
- BEONE MEDICINES LTD-ADR-$2.1M -17.4%
- VERTEX PHARMACEUTICALS INC-$1.7M -14.9%
- CELCUITY INC-$1.7M -32.2%
Exited Positions
- AMGEN INC$8.7M
- UNIVERSAL HEALTH SERVICES INC$2.8M
- SOLENO THERAPEUTICS INC$2.2M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | ELI LILLY & CO | LLY | 532457108 | $35.8M | 9.62% | 29,821 | SH |
| 2 | MERCK & CO. INC | MRK | 58933Y105 | $24.3M | 6.55% | 189,357 | SH |
| 3 | JOHNSON & JOHNSON | JNJ | 478160104 | $21.7M | 5.84% | 85,425 | SH |
| 4 | ABBVIE INC | ABBV | 00287Y109 | $16.2M | 4.35% | 64,325 | SH |
| 5 | CVS HEALTH CORP | CVS | 126650100 | $15.1M | 4.07% | 146,102 | SH |
| 6 | THERMO FISHER SCIENTIFIC CORP | TMO | 883556102 | $14.0M | 3.76% | 27,859 | SH |
| 7 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $13.7M | 3.68% | 73,077 | SH |
| 8 | BIOGEN INC | BIIB | 09062X103 | $13.6M | 3.65% | 62,781 | SH |
| 9 | NEUROCRINE BIOSCIENCES INC | NBIX | 64125C109 | $12.3M | 3.31% | 72,898 | SH |
| 10 | MIRUM PHARMACEUTICALS INC | MIRM | 604749101 | $11.8M | 3.17% | 100,807 | SH |
| 11 | ALKERMES PLC | ALKS | G01767105 | $11.2M | 3.01% | 213,329 | SH |
| 12 | IONIS PHARMACEUTICALS INC | IONS | 462222100 | $10.9M | 2.93% | 137,131 | SH |
| 13 | BEONE MEDICINES LTD-ADR | ONC | 07725L102 | $10.0M | 2.70% | 35,180 | SH |
| 14 | INTUITIVE SURGICAL INC | ISRG | 46120E602 | $9.8M | 2.64% | 24,656 | SH |
| 15 | STRYKER CORPORATION | SYK | 863667101 | $9.5M | 2.57% | 30,283 | SH |
| 16 | VERTEX PHARMACEUTICALS INC | VRTX | 92532F100 | $9.5M | 2.56% | 19,131 | SH |
| 17 | EDWARDS LIFESCIENCES CORP | EW | 28176E108 | $9.3M | 2.51% | 103,230 | SH |
| 18 | BRIDGEBIO PHARMA INC | BBIO | 10806X102 | $9.3M | 2.50% | 124,707 | SH |
| 19 | KRYSTAL BIOTECH, INC | KRYS | 501147102 | $8.9M | 2.40% | 24,019 | SH |
| 20 | CENCORA INC | COR | 03073E105 | $8.8M | 2.37% | 31,126 | SH |
| 21 | NEWAMSTERDAM PHARMA CO NV | NAMS | N62509109 | $8.4M | 2.27% | 248,848 | SH |
| 22 | ABIVAX SA | ABVX | 00370M103 | $7.8M | 2.09% | 58,170 | SH |
| 23 | INCYTE CORP | INCY | 45337C102 | $6.5M | 1.74% | 56,953 | SH |
| 24 | IRHYTHM TECHNOLOGIES INC | IRTC | 450056106 | $6.4M | 1.73% | 54,102 | SH |
| 25 | BOSTON SCIENTIFC | BSX | 101137107 | $6.2M | 1.68% | 146,381 | SH |
| 26 | INSMED INC | INSM | 457669307 | $6.2M | 1.67% | 58,378 | SH |
| 27 | TANGO THERAPEUTICS INC | TNGX | 87583X109 | $6.2M | 1.67% | 198,557 | SH |
| 28 | GILEAD SCIENCES INC | GILD | 375558103 | $5.8M | 1.57% | 46,142 | SH |
| 29 | CARDINAL HEALTH INC | CAH | 14149Y108 | $5.6M | 1.51% | 23,630 | SH |
| 30 | ORUKA THERAPEUTI | ORKA | 687604108 | $5.2M | 1.41% | 54,886 | SH |
| 31 | SPYRE THERAPEUTICS INC | SYRE | 00773J202 | $5.1M | 1.36% | 57,030 | SH |
| 32 | DEXCOM INC | DXCM | 252131107 | $4.8M | 1.30% | 71,846 | SH |
| 33 | BICARA THERAPEUTICS INC | BCAX | 055477103 | $4.3M | 1.16% | 145,657 | SH |
| 34 | IDEAYA BIOSCIENCES INC | IDYA | 45166A102 | $3.5M | 0.95% | 94,478 | SH |
| 35 | CELCUITY INC | CELC | 15102K100 | $3.5M | 0.94% | 33,313 | SH |
| 36 | DISC MEDICINE INC | IRON | 254604101 | $3.2M | 0.86% | 43,682 | SH |
| 37 | PYXIS ONCOLOGY INC | PYXS | 747324101 | $2.9M | 0.78% | 966,459 | SH |
| 38 | COMPASS THERAPEUTICS INC | CMPX | 20454B104 | $2.3M | 0.62% | 1,048,593 | SH |
| 39 | JADE BIOSCIENCES | JBIO | 008064206 | $2.0M | 0.53% | 88,556 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-07-24 | $371.7M | 39 | 0001381843-26-000005 |
| 2026-03-31 | 2026-05-11 | $309.7M | 39 | 0001381843-26-000004 |
| 2025-12-31 | 2026-02-06 | $313.4M | 39 | 0001381843-26-000002 |
| 2025-09-30 | 2025-11-04 | $27.0M | 38 | 0001381843-25-000009 |